Evidence map›Paper›PMID 32454726›Full record

ArticleTurkish journal of pharmaceutical sciences2019

An

Deniz Özkan Vardar, Sevtap Aydin, İbrahim Hocaoğlu, Havva Yağci Acar, Nursen Başaran

Open access · diamondAbstract read
In one paragraph

Article in Turkish journal of pharmaceutical sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. BiogenicToxicology research · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Deniz Özkan VardarHitit University, Sungurlu Vocational High School, Health Programs, Çorum, Turkey.ORCID https://orcid.org/0000-0003-0976-9556
Sevtap AydinHacettepe University, Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Ankara, Turkey.ORCID https://orcid.org/0000-0002-6368-2745
İbrahim HocaoğluKoç University, Graduate School of Materials Science and Engineering, İstanbul, Turkey.ORCID https://orcid.org/0000-0001-1875-5148
Havva Yağci AcarKoç University, College of Sciences, Department of Chemistry, İstanbul, Turkey.ORCID https://orcid.org/0000-0001-5601-8814
Nursen BaşaranHacettepe University, Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Ankara, Turkey.ORCID https://orcid.org/0000-0001-8581-8933
Hacettepe University · TRKoç University · TRHitit Üniversitesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesSilver sulfide (Ag MATERIALS AND

methodsCell viability was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and neutral red uptake (NRU) assays. The genotoxic and apoptotic effects of DMSA/Ag

resultsCell viability was 54.0±4.8% and 65.7±4.1% at the highest dose (2000 μg/mL) of Ag

conclusionThe cytotoxic effects of DMSA/Ag

Indexed as

3-dimercaptosuccinic acid coated silver sulfide quantum dotsapoptosisgenotoxicityMeso-2

Identifiers

PMID32454726
PMCPMC7227946
OpenAlexW2806042071

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.